Patient-Reported Quality of Life After Intravenous Alteplase for Stroke in the WAKE-UP Trial.

Märit JensenSusanne SehnerBastian ChengEckhard Schlemm Fanny QuandtEwgenia BarowKarl WegscheiderFlorent BoutitieMartin EbingerMatthias EndresJochen B Fiebach Vincent N Thijs Robin Lemmens Keith W MuirNorbert NighoghossianSalvador PedrazaClaus Z SimonsenGötz ThomallaChristian Gerloff

Published in: Neurology (2022)

Assessment of patient-reported outcome measures reveals a potential benefit of intravenous alteplase for HRQoL beyond improvement of functional outcome.

Keyphrases

patient reported
acute ischemic stroke
high dose
study protocol
clinical trial
phase iii
phase ii
randomized controlled trial
low dose
human health
brain injury